Efficacy of arbidol in COVID-19 patients: A retrospective study

Table 4 Single and multifactor analyses of variance identify high lactate dehydrogenase, ferritin, and no arbidol treatment as independent risk factors for long disease duration

	Single factor		Multi factor
	OR (95%CI)	P value	OR (95%CI)	P value
Nontreatment	8.167 (3.731-17.874)	< 0.001	7.158 (2.608-19.648)	< 0.001
Ferritin (> 486.5 ng/mL）	4.368 (1.895-10.066)	0.001	2.852 (1.004-8.099)	0.049
LDH (> 239.5 U/L)	8.167 (3.731,17.874)	< 0.001	5.946 (2.171-16.285)	0.001
Age (> 60 yr)	0.699 (0.334-1.338)	0.255
Male gender	0.628 (0.310-1.273)	0.197
Underlying disease (yes vs none)	1.421 (0.674-2.996)	0.356
Abnormal liver function1 (yes vs none)	1.229 (0.607-2.487)	0.567
Abnormal heart function2 (yes vs none)	0.242 (0.027-2.132)	0.201
Abnormal creatinine2 (yes vs none)	1.281 (0.078-20.922)	0.862

¹Chi-square test.

²Fisher’s exact test. LDH: Lactate dehydrogenase; OR: Odds ratio.